Big price increase! 40 medicines in short supply

▍ finishing: Banxia On November 14, Guizhou public resources trading center issued the notice on the announcement of the independent quotation of domestic drugs, and the quotation of 40 drugs in short supply was made public According to the notice, there are 40 products in the list of drugs in short supply in Guizhou Province (the second batch), including nitroglycerin tablets, allopurinol tablets, cytarabine hydrochloride for injection, actinomycin D for injection, bromepyridine tablets, methimazole tablets and so on Compared with the price of some products in Guizhou Province, the price of this time's quotation has a significant increase For example, the price of allopurinol tablets (0.1g * 100 tablets) of a pharmaceutical company in Guizhou is 92 yuan this time According to the query of the bidding database of minenet, the price of the product in Guizhou was 58 yuan, an increase of 37% Another example is scopolamine hydrobromide injection (1ml: 0.3mg) from a pharmaceutical company The price of scopolamine hydrobromide injection in Guizhou is 68 yuan this time It was found by querying the bidding database of minenet that the price of the product in Guizhou was 24.5 yuan before, with an increase of 64% In addition, the notice also reminded that for the quoted products, the drugs that have not declared the qualification certification materials should declare the qualification certification materials according to the regulations, and the declaration time of the qualification certification materials is from 9:00 on November 18 to 17:00 on November 24 In recent years, there have been many "rocket" drug price increases According to media reports, there are more than 100 kinds of drugs with abnormal price increases, most of which are 3-10 times, some of which are dozens or even hundreds of times Compared with the simple price hike, there are many commonly used drugs in short supply Besides the price hike, they were once out of stock For example, the Qilu Evening News recently reported that in February this year, only three of the 19 drugstores in different regions of Jinan had 100 pieces of nitroglycerin tablets in stock Many drugstores said that the product was out of stock years ago Saibailan visited many chain drugstores in Guangzhou and found that nitroglycerin, a common drug for patients with coronary heart disease and angina pectoris, was out of stock for half a year More recently, Hunan Public Resources Trading Center issued a notice saying that six drugs, such as aminomethylbenzoic acid tablets, are currently out of stock or in short supply due to no replacement in clinical practice, and cannot be restored in a short period of time Now, the original online price is cancelled and included in the direct online price, which is directly negotiated and purchased by medical institutions and pharmaceutical enterprises As another example, the people's Hospital of Xiangzhou District, Zhuhai City, Guangdong Province, previously issued an inquiry notice on drugs in short supply, saying that allopurinol tablets were included in the "purchase of drugs that cannot be supplied online", indicating that the drugs could not be purchased online, resulting in a shortage or shortage of goods in the hospital Mercaptopurine, an indispensable life-saving drug for childhood acute lymphoblastic leukemia (all), has been out of stock for many times in China in recent years There are many similar examples From the above mentioned rise in price and shortage of drugs, there are many reasons for the rise in price of drugs that cannot be separated from the rise in the price of raw materials, and the reason for the shortage of raw materials For example, at the end of last year, there was a commercial company sent to the hospital about the shortage of lidocaine hydrochloride glue, which was circulated in the industry The reason for the shortage was that the manufacturer had no raw materials and could not produce it According to relevant pharmaceutical companies, many cheap and high-quality drugs are out of stock due to the artificial control of raw materials, resulting in a large increase in the production cost of manufacturers without raw materials This is a common phenomenon in the pharmaceutical industry in recent two years The price of raw materials for drugs such as isoniazid and chlorpheniramine has risen from 2000 yuan per kilogram to 50000 yuan Fang Zhiwu, a former member of the medical reform expert committee of the State Council, said in an interview with CCTV finance and economics that APIs are raw materials of medicines Why chip? First, the content is very low, only a few milligrams in a drug Second, it's extremely important Like a computer, chips can play an important role Without these milligrams, the medicine won't work Although there may also be some benign governance factors, resulting in price increases, such as environmental protection, urbanization, and some disordered production before governance, resulting in some cost increases, but such increases are usually within the scope of 20% and 30%, which can be accepted by everyone, and the state is willing to give subsidies, so that manufacturers can basically maintain production and make reasonable profits However, there are always some people trying to use the market to make huge profits This kind of abnormal surge, dozens of times of surge, there are usually reasons for malicious control of sales channels Attached: self quotation of drugs in the list of short drugs in Guizhou Province (the second batch)